A pilot project with Kaunas Clinical Hospital, Lithuania (2,000 beds) is currently being launched. Atrial fibrillation is the most common long-term heart rhythm disorder. Atrial fibrillation significantly increases the risk of ischemic stroke, sudden death, increases in overall mortality, and may lead to heart failure. Early diagnosis of AF allows timely initiation of treatment, protecting the patient from disease progression and possible complications.
Not all patients felt symptoms of atrial fibrillation. There are people who may not feel it at all when their heart rhythm is disturbed. Only with the advent of permanent portable electrocardiographs would it be easier to identify, assess and treat this arrhythmia. The aim of this pilot project is to test an electrocardiograph based on a smart t-shirt designed by our team.
The ECG will be monitored on the patient’s mobile phone and on two computers by the cardiologist, where the ECG parameters will be presented and calculated. Due to the risk of heart attack will be automatically monitored ST elevation range. This will avoid direct contact between the patient and the cardiologist, reducing time spent in queues. This is especially important during the COVID19 period.
More information is in the attachment and on Youtube: